Newark, DE, United States of America

Martin A Drinan

USPTO Granted Patents = 8 

 

Average Co-Inventor Count = 3.9

ph-index = 2

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2016-2024

Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: **The Innovations of Martin A. Drinan: A Pioneering Mind in Biotech**

Introduction

Martin A. Drinan is an accomplished inventor based in Newark, Delaware, whose contributions to the field of biotechnology have resulted in eight patents. His expertise lies in developing innovative solutions that enhance biochemical assays, particularly those involving biotin and drugs binding to specific proteins.

Latest Patents

Drinan's recent patents showcase advanced technology in microfluidics and chemiluminescent detection systems. One of his notable inventions is a kit designed for performing biotin assays. This kit utilizes a sensitizer that generates singlet oxygen in its excited state, alongside methods to determine the concentration of biotin in a sample. The integration of a singlet oxygen-activatable chemiluminescent compound, which has biotin or its analog bound to it, highlights Drinan's forward-thinking approach.

Additionally, he has developed methods and kits for determining the levels of specific drugs in samples containing binding proteins. This innovative patent includes analog compounds that displace drugs from their endogenous binding proteins, thereby providing novel assay procedures for pharmaceutical diagnostics.

Career Highlights

Drinan is affiliated with Siemens Healthcare Diagnostics GmbH, where he continues to push the boundaries of biotech innovations. His work involves collaborating closely with his team to develop groundbreaking technologies that influence the medical diagnostics field.

Collaborations

Throughout his career, Martin A. Drinan has partnered with talented individuals, including coworkers Zhu Teng and Tie Q. Wei. These collaborations have undoubtedly enriched his research endeavors and contributed significantly to his ability to create impactful inventions.

Conclusion

In conclusion, Martin A. Drinan's contributions to the field of biotechnology are marked by a series of innovative patents that address critical issues in drug binding and biomolecule detection. His ongoing work at Siemens Healthcare Diagnostics GmbH and collaborations with fellow scientists highlight his commitment to advancing technology that aids in pharmaceutical research and diagnostics. As he continues to explore new frontiers in his field, Drinan's inventions promise to shape the future of health diagnostics.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…